^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Xerna TME™ Panel

    Company:
    Feng Biosciences
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    The Xerna TME Panel uses proprietary RNA-based gene expression data and a machine learning-based algorithm to classify patients based on the interplay between angiogenic and immunogenic dominant biologies of the tumor microenvironment (TME). The Xerna TME Panel is an investigational assay and has not been approved by the FDA.